|
Apax Partners Apax Partners is one of the world’s leading private equity investment groups. Founded in 1972 in the United States and in Europe, Apax Partners currently has over EUR 7 billion under management or advice on behalf of leading institutional investors around the world. Apax Partners pursues a balanced equity portfolio strategy, investing in growth companies at all stages of development from start-up to buyout in its chosen sectors, namely: information technology, telecommunications, healthcare, media, internet, financial services and retail and consumer products. www.apax.com |
|
Atlas Venture GmbH Atlas Venture is a leading international venture capital firm focused on early stage investments in three interconnected areas of digital economy: e-commerce, communications and health. Atlas Venture was founded in 1980 and has offices in the US (Boston, Seattle and Silicon Valley) and Europe (Amsterdam, Munich, London and Paris). Atlas Venture is managed by a worldwide team of 22 investment professionals who are market and technology specialists, seasoned operating executives, and career venture capitalists. Our Principals have been deeply involved in the information and development of over 200 companies internationally as entrepreneurs and venture capitalists. www.atlasventure.com |
|
EDventure Holdings EDventure Holdings publishes the influential monthly computer-industry newsletter, Release 1.0, and sponsors two of the industry’s premier conferences, PC Forum in the US and EDventure’s High-Tech Forum in Europe.. www.edventure.com |
|
Extorel Company Profile to follow shortly. www.extorel.de |
|
Internet Capital Group |
|
Israel Seed Partners |
|
Katan Associates |
|
Medigene AG MediGene (NMarkt: MDG) is a publicly quoted bio-pharmaceutical that combines a broad technology platform with products in pre-clinical and clinical development. The company has built up core competence in cardiac and cancer diseases and employs modern approaches in biochemistry, molecular biology, genomics, proteomics and immunology. Founded in 1994, MediGene now has 93 employees (as of November 1, 2000). MediGene recently announced the signing of an acquisition agreement with NeuroVir Therapeutics, Inc. The proposed transaction will increase the number of MediGenešs product candidates in clinical development from three to five. Strategic product alliances with Schering and Aventis Pharma have been concluded for the development and the marketing of two of MediGene’s vaccines. However, the company also intends to market certain products on its own. www.medigene.de |
|
New Venturetec |
|
Nokia Venture Partners |
|
Novartis Venture Fund |
|
Polaris Venture Capital Polaris Venture Capital is a leading venture capital firm originated in Israel. To date, the firm has provided value-added investing to more than 70 high-tech companies in Israel, in the fields of telecommunication, data communications, Internet infrastructure, medical devices and biotechnology. Many Polaris portfolio companies have gone public in the United States and Europe, including ITXC, AudioCodes, BackWeb, Radware, and VocalTec. Polaris operates as the lead investor in seed, early, and expansion-stage companies, and takes an active role in each company’s Board of Directors. The firm currently manages four venture funds totaling $700 million in committed capital. www.polarisvc.com |
|
T-Venture Of the EUR 400 million of capital currently available, 80 per cent is earmarked for direct investment, and 20 per cent indirectly via VC funds. Each direct investment is in the region of EUR 0.5 to 5 million (although larger amounts are possible), and – as a matter of policy – all investments are minority interests. The preferred financing stages are seed money, start-up financing and expansion financing. Direct investments in suitable companies are undertaken by subsidiaries of the holding company , and managed by “professional” in-house investment managers of which there are currently twenty-two. In parallel, T-Venture also has equity interests in domestic and international VC funds with external venture managers who undertake investments in growth companies and offer T-Venture opportunities for co-investment. In terms of geographical spread, most of the investments are in Europe and the USA. where T-Venture is represented by its own subsidiary (T-Venture of America, Inc) T-Venture has offices in Berlin, Darmstadt, Munich, Boston (MA, USA), Redwood City (CA, USA), Tokyo and Singapore. The present T-Venture portfolio (with an investment cost of approx (EUR 160 m) currently includes 48 businesses (as at December 31, 2000) plus 10 fund holdings. Eight IPO flotations and a successful “trade sale” enabled the portfolio’s value to be tripled within a short period of time. www.telekom.de |
|
Viventures Partners Viventures invests in start-ups or expanding businesses
with innovative Internet and telecommunications strategies. The
Fund provides seed capital and supports these newly founded companies
in order to ensure their long-term development in Europe as well
as in the United States. The Fund’s ultimate goal is to enable
these companies to go public on one of the Stock Market’s “new
markets”. |
|
Wanadoo |
|
Warburg Pincus E. M. Warburg Pincus & Co., LLC (“Warburg Pincus”) is a major global private equity investment firm. Over the past 30 years, it has invested in more than 400 companies worldwide. It is currently managing $10 billion of investments, with a further $4 billion available for investment.. www.warburgpincus.com |